Topic 345 - sbir phase II: radtox - measuring radiation toxicity using circulating DNA
Ended Definitive Contract Awarded Last action
- Contract number
- 75N91018C00036
- Awardee
-
Diacarta L.L.C. UEI Q25LJZJK2BR1
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $0
Award facts
- Opportunity
-
- BAAN44CO8900149 Solicitation number
- Contract value
- $0.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- Set-aside
- Total Small Business
- Competition
- Full and Open Competition after exclusion of sources · 1 offer Negotiated Proposal / Quote
- Pricing
- Cost No Fee
- Place of performance
- San Pablo, CA, USA
- Research
- SBIR Program Phase II Action
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$1,999,984 | |
| Original award | $1,999,984 |
Quick answers
Who was awarded contract 75N91018C00036?
75N91018C00036 was awarded to Diacarta L.L.C. by National Cancer Institute (National Institutes of Health) on September 17, 2018.
How much is contract 75N91018C00036 worth?
The government has obligated $0 on 75N91018C00036.
Was contract 75N91018C00036 competed?
The extent of competition for 75N91018C00036 was full and open competition after exclusion of sources. The government received 1 offer. It was set aside: Total Small Business.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award